BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
124 hedge funds and large institutions have $1.81B invested in Blueprint Medicines in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
-10
Holders Change %
-7.46%
% of All Funds
3.1%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.17%
New
23
Increased
54
Reduced
35
Closed
33
Calls
$2.75M
Puts
$4.26M
Net Calls
-$1.5M
Net Calls Change
-$2.41M
Top Buyers
| 1 |
O
1
OppenheimerFunds
New York
|
$77.3M |
| 2 |
2
BlackRock
New York
|
$145M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$70.9M |
| 4 |
TCM
4
TimesSquare Capital Management
New York
|
$28.4M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$269M |
